Quanterix Corporation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Quanterix Corporation (QTRX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -0.30% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2025-03-17
- Quanterix Corporation effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -0.30%.
- Quanterix Corporation effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -0.60%.
- Quanterix Corporation effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -0.30%.
- Quanterix Corporation effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was -1.90%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -0.30% 10-K · filed 2025-03-17 | |
| 2023-12-31 | -0.60% 10-K · filed 2025-03-17 | -0.50% 10-K · filed 2024-02-29 |
| 2022-12-31 | -0.30% 10-K · filed 2025-03-17 | |
| 2021-12-31 | -1.90% 10-K/A · filed 2024-12-26 | -1.80% 10-K · filed 2022-03-01 |
| 2020-12-31 | -0.40% 10-K · filed 2023-03-06 | |
| 2019-12-31 | -0.90% 10-K · filed 2022-03-01 | |
| 2018-12-31 | -1.20% 10-K · filed 2021-03-05 | |
| 2017-12-31 | -1.60% 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |